Ubiquitination regulates the assembly of VLDL in HepG2 cells and is the committing step of the apoB-100 ERAD pathway

Journal of Lipid Research

Volumn 52, Issue 6, 2011, Pages 1170-1180

  Fisher, Eric A ^a   Khanna, Neeraj A ^a   McLeod, Roger S ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Apolipoprotein B 100; Endoplasmic reticulum associated degradation; Very low density lipoprotein

Indexed keywords

APOLIPOPROTEIN B100; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TRIACYLGLYCEROL; UBIQUITIN LIGASE GP78; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; CELL STRAIN HEPG2; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REGULATORY MECHANISM; UBIQUITINATION;

EID: 79956050306     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M011726     Document Type: Article

References (39)

1. Shelness, G. S., and A. S. Ledford. 2005. Evolution and mechanism of apolipoprotein B-containing lipoprotein assembly. Curr. Opin. Lipidol. 16: 325-332.
2. Lapierre, L. R., and R. S. McLeod. 2007. Regulation of hepatic production of lipoproteins containing apolipoprotein B by ER-associated degradation. Future Lipidol. 2: 173-184.
3. Benoist, F., and T. Grand-Perret. 1997. Co-translational degradation of apolipoprotein B100 by the proteasome is prevented by microsomal triglyceride transfer protein. Synchronized translation studies on HepG2 cells treated with an inhibitor of microsomal triglyceride transfer protein. J. Biol. Chem. 272: 20435-20442.
4. Dixon, J. L., S. Furukawa, and H. N. Ginsberg. 1991. Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B. J. Biol. Chem. 266: 5080-5086.
5. Zhou, M., E. A. Fisher, and H. N. Ginsberg. 1998. Regulated cotranslational ubiquitination of apolipoprotein B100. A new paradigm for proteasomal degradation of a secretory protein. J. Biol. Chem. 273: 24649-24653.
6. Lapierre, L. R., D. L. Currie, Z. Yao, J. Wang, and R. S. McLeod. 2004. Amino acid sequences within the b 1 domain of human apolipoprotein B can mediate rapid intracellular degradation. J. Lipid Res. 45: 366-377.
7. Vembar, S. S., and J. L. Brodsky. 2008. One step at a time: endoplasmic reticulum-associated degradation. Nat. Rev. Mol. Cell Biol. 9: 944-957.
8. Rutledge, A. C., Q. Su, and K. Adeli. 2010. Apolipoprotein B100 biogenesis: a complex array of intracellular mechanisms regulating folding, stability, and lipoprotein assembly. Biochem. Cell Biol. 88: 251-267.
9. Sakata, N., X. Wu, J. L. Dixon, and H. N. Ginsberg. 1993. Proteolysis and lipid-facilitated translocation are distinct but competitive processes that regulate secretion of apolipoprotein B in Hep G2 cells. J. Biol. Chem. 268: 22967-22970.
10. Mitchell, D. M., M. Zhou, R. Pariyarath, H. Wang, J. D. Aitchison, H. N. Ginsberg, and E. A. Fisher. 1998. Apoprotein B100 has a prolonged interaction with the translocon during which its lipidation and translocation change from dependence on the microsomal triglyceride transfer protein to independence. Proc. Natl. Acad. Sci. USA. 95: 14733-14738.
11. Rutledge, A. C., W. Qiu, R. Zhang, R. Kohen-Avramoglu, N. Nemat-Gorgani, and K. Adeli. 2009. Mechanisms targeting apolipoprotein B100 to proteasomal degradation: evidence that degradation is initiated by BiP binding at the N terminus and the formation of a p97 complex at the C terminus. Arterioscler. Thromb. Vasc. Biol. 29: 579-585.
12. Fisher, E. A., L. R. Lapierre, R. D. Junkins, and R. S. McLeod. 2008. The AAA-ATPase p97 facilitates degradation of apolipoprotein B by the ubiquitin-proteasome pathway. J. Lipid Res. 49: 2149-2160.
13. Zhou, M., X. Wu, L. S. Huang, and H. N. Ginsberg. 1995. Apoprotein B100, an inefficiently translocated secretory protein, is bound to the cytosolic chaperone, heat shock protein 70. J. Biol. Chem. 270: 25220-25224.
14. Gusarova, V., A. J. Caplan, J. L. Brodsky, and E. A. Fisher. 2001. Apoprotein B degradation is promoted by the molecular chaperones hsp90 and hsp70. J. Biol. Chem. 276: 24891-24900.
15. Liang, J. S., T. Kim, S. Fang, J. Yamaguchi, A. M. Weissman, E. A. Fisher, and H. N. Ginsberg. 2003. Overexpression of the tumor autocrine motility factor receptor Gp78, a ubiquitin protein ligase, results in increased ubiquitinylation and decreased secretion of apolipoprotein B100 in HepG2 cells. J. Biol. Chem. 278: 23984-23988.
16. Zhong, X., Y. Shen, P. Ballar, A. Apostolou, R. Agami, and S. Fang. 2004. AAA ATPase p97/valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation. J. Biol. Chem. 279: 45676-45684.
17. Tsai, J., W. Qiu, R. Kohen-Avramoglu, and K. Adeli. 2007. MEKERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB-100 particle assembly. Arterioscler. Thromb. Vasc. Biol. 27: 211-218.
18. Cavallo, D., R. S. McLeod, D. Rudy, A. Aiton, Z. Yao, and K. Adeli. 1998. Intracellular translocation and stability of apolipoprotein B are inversely proportional to the length of the nascent polypeptide. J. Biol. Chem. 273: 33397-33405.
19. McLeod, R. S., Y. Wang, S. Wang, A. Rusinol, P. Links, and Z. Yao. 1996. Apolipoprotein B sequence requirements for hepatic very low density lipoprotein assembly. J. Biol. Chem. 271: 18445-18455.
20. Wang, Y., R. S. McLeod, and Z. Yao. 1997. Normal activity of microsomal triglyceride transfer protein is required for the oleateinduced secretion of very low density lipoproteins containing apolipoprotein B from McA-RH7777 cells. J. Biol. Chem. 272: 12272-12278.
21. Zhang, K., and R. J. Kaufman. 2008. From endoplasmic-reticulum stress to the inflammatory response. Nature. 454: 455-462.
22. Tower, J. 2009. Hsps and aging. Trends Endocrinol. Metab. 20: 216-222.
23. Borchardt, R. A., and R. A. Davis. 1987. Intrahepatic assembly of very low density lipoproteins. Rate of transport out of the endoplasmic reticulum determines rate of secretion. J. Biol. Chem. 262: 16394-16402.
24. Macri, J., and K. Adeli. 1997. Conformational changes in apolipoprotein B modulate intracellular assembly and degradation of ApoB-containing lipoprotein particles in HepG2 cells. Arterioscler. Thromb. Vasc. Biol. 17: 2982-2994.
25. Ballar, P., and S. Fang. 2008. Regulation of ER-associated degradation via p97/VCP-interacting motif. Biochem. Soc. Trans. 36: 818-822.
26. Nakatsukasa, K., and J. L. Brodsky. 2008. The recognition and retrotranslocation of misfolded proteins from the endoplasmic reticulum. Traffic. 9: 861-870.
27. Wang, L., D. D. Martin, E. Genter, J. Wang, R. S. McLeod, and D. M. Small. 2009. Surface study of apoB1694-1880, a sequence that can anchor apoB to lipoproteins and make it nonexchangeable. J. Lipid Res. 50: 1340-1352.
28. Dixon, J. L., R. Chattapadhyay, T. Huima, C. M. Redman, and D. Banerjee. 1992. Biosynthesis of lipoprotein: location of nascent apoAI and apoB in the rough endoplasmic reticulum of chicken hepatocytes. J. Cell Biol. 117: 1161-1169.
29. Adeli, K., M. Wettesten, L. Asp, A. Mohammadi, J. Macri, and S. O. Olofsson. 1997. Intracellular assembly and degradation of apolipoprotein B-100-containing lipoproteins in digitonin-permeabilized HEP G2 cells. J. Biol. Chem. 272: 5031-5039.
30. Gusarova, V., J. Seo, M. L. Sullivan, S. C. Watkins, J. L. Brodsky, and E. A. Fisher. 2007. Golgi-associated maturation of very low density lipoproteins involves conformational changes in apolipoprotein B, but is not dependent on apolipoprotein E. J. Biol. Chem. 282: 19453-19462.
31. Du, X., J. D. Stoops, J. R. Mertz, C. M. Stanley, and J. L. Dixon. 1998. Identification of two regions in apolipoprotein B100 that are exposed on the cytosolic side of the endoplasmic reticulum membrane. J. Cell Biol. 141: 585-599.
32. Yang, H., C. Liu, Y. Zhong, S. Luo, M. J. Monteiro, and S. Fang. 2010. Huntingtin interacts with the cue domain of gp78 and inhibits gp78 binding to ubiquitin and p97/VCP. PLoS ONE. 5: e8905.
33. Wojcik, C., M. Rowicka, A. Kudlicki, D. Nowis, E. McConnell, M. Kujawa, and G. N. DeMartino. 2006. Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells. Mol. Biol. Cell. 17: 4606-4618.
34. Alzayady, K. J., M. M. Panning, G. G. Kelley, and R. J. Wojcikiewicz. 2005. Involvement of the p97-Ufd1-Npl4 complex in the regulated endoplasmic reticulum-associated degradation of inositol 1,4,5- trisphosphate receptors. J. Biol. Chem. 280: 34530-34537.
35. Ron, D., and P. Walter. 2007. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 8: 519-529.
36. Ota, T., C. Gayet, and H. N. Ginsberg. 2008. Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents. J. Clin. Invest. 118: 316-332.
37. Su, Q., J. Tsai, E. Xu, W. Qiu, E. Bereczki, M. Santha, and K. Adeli. 2009. Apolipoprotein B100 acts as a molecular link between lipid-induced endoplasmic reticulum stress and hepatic insulin resistance. Hepatology. 50: 77-84.
38. Sniderman, A. D., J. De Graaf, P. Couture, K. Williams, R. S. Kiss, and G. F. Watts. 2009. Regulation of plasma LDL: the apoB paradigm. Clin. Sci. (Lond.). 118: 333-339.
39. Calderwood, S. K., A. Murshid, and T. Prince. 2009. The shock of aging: molecular chaperones and the heat shock response in longevity and aging - a mini-review. Gerontology. 55: 550-558.